Cytokinetics CYTK Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Cytokinetics’s reported figures.
Based on the most recent quarter.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's quick ratio?
- Cytokinetics (CYTK) reported quick ratio of 4.2× in Q1 2026.
- How has Cytokinetics's quick ratio changed year-over-year?
- Cytokinetics's quick ratio decreased by 29.9% year-over-year, from 6× to 4.2×.
- What is the long-term trend for Cytokinetics's quick ratio?
- Over 5 years (2020 to 2025), Cytokinetics's quick ratio has grown at a -21.5% compound annual growth rate (CAGR), from 15.2× to 4.5×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.